Ghent University Academic Bibliography

Your filters: cql: author="Gerlach, Oliver" or (type any "bookEditor issueEditor" and editor="Gerlach, Oliver")

Add to list
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Yi Chao Foong, Daniel Merlo, Melissa Gresle, Katherine Buzzard, Dana Horakova, Eva Kubala Havrdova, Tomas Kalincik, Izanne Roos, Suzanne Hodgkinson, Jeannette Lechner-Scott, et al.

(2026) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 97(1). p.50-58
Add to list
- Journal Article
- A1
- open access
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

Tomas Kalincik, Sifat Sharmin, Izanne Roos, Mark S Freedman, Harold Atkins, Jennifer Massey, Ian Sutton, Barbara Withers, Joachim Burman, Øivind Torkildsen, et al.

(2026) BRAIN. 149(3). p.951-962
Add to list
Effect of late-onset on multiple sclerosis phenotype and outcome : evidence from a multi-national registry

Amira Souissi, Francesco Patti, Tim Spelman, Clara Chisari, Amina Gargouri, Nevin John, Allan G. Kermode, Tomas Kalincik, Helmut Butzkueven, Seyed Aidin Sajedi, et al.

(2026) JOURNAL OF NEUROLOGY. 273(2).
Add to list
- Miscellaneous
Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability progression in people with multiple sclerosis

Hamza Khan, Henry C Woodruff, Diana L. Giraldo, Lorin Werthen-Brabants (UGent) , Shruti Atul Mali, Sina Amirrajab, Edward De Brouwer, Veronica Popescu, Bart Van Wijmeersch, Oliver Gerlach, et al.

(2025) medRxiv.
Add to list
- Journal Article
- A1
- open access
Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability worsening in people with multiple sclerosis

Hamza Khan, Henry C. Woodruff, Diana L. Giraldo, Lorin Werthen-Brabants (UGent) , Shruti Atul Mali, Sina Amirrajab, Edward De Brouwer, Veronica Popescu, Bart Van Wijmeersch, Oliver Gerlach, et al.

(2025) FRONTIERS IN NEUROSCIENCE. 19.
Add to list
- Journal Article
- A1
- open access
Managing reactivation of multiple sclerosis during treatment with natalizumab

Nathaniel Lizak, Sifat Sharmin, Dana Horáková, Eva Kubala Havrdova, Sara Eichau, Anneke van der Walt, Helmut Butzkueven, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, et al.

(2025) MULTIPLE SCLEROSIS JOURNAL. 32(1). p.121-133
Add to list
Explainable time-to-progression predictions in multiple sclerosis

Robbe D’hondt, Klest Dedja, Sofie Aerts, Bart Van Wijmeersch, Tomas Kalincik, Stephen Reddel, Eva Kubala Havrdova, Alessandra Lugaresi, Bianca Weinstock-Guttman, Saloua Mrabet, et al.

(2025) COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 263.
Add to list
- Journal Article
- A2
- open access
Persistent progression independent of relapse activity in multiple sclerosis

Chao Zhu, Zhen Zhou, Tomas Kalincik, Izanne Roos, Katherine Buzzard, Olga Skibina, Raed Alroughani, Jens Kuhle, Marc Girard, Pierre Grammond, et al.

(2025) BRAIN COMMUNICATIONS. 7(5).
Add to list
- Journal Article
- A1
- open access
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Simona Toscano, Tim Spelman, Serkan Ozakbas, Raed Alroughani, Clara G. Chisari, Salvatore Lo Fermo, Alexandre Prat, Marc Girard, Pierre Duquette, Guillermo Izquierdo, et al.

(2025) NEUROTHERAPEUTICS. 22(2).
Add to list
- Journal Article
- A1
- open access
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Ashkan Pirmani, Edward De Brouwer, Ádám Arany, Martijn Oldenhof, Antoine Passemiers, Axel Faes, Tomas Kalincik, Serkan Ozakbas, Riadh Gouider, Barbara Willekens, et al.

(2025) NPJ DIGITAL MEDICINE. 8(1).

Academic Bibliography

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

Effect of late-onset on multiple sclerosis phenotype and outcome : evidence from a multi-national registry

Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability progression in people with multiple sclerosis

Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability worsening in people with multiple sclerosis

Managing reactivation of multiple sclerosis during treatment with natalizumab

Explainable time-to-progression predictions in multiple sclerosis

Persistent progression independent of relapse activity in multiple sclerosis

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Contents

Support

Contact